 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/25/2023 |
$58.05 |
$58.83 |
$57.90 |
$58.75 |
1.90M | | 09/26/2023 |
$58.56 |
$59.62 |
$58.52 |
$59.28 |
1.47M | | 09/27/2023 |
$59.46 |
$59.85 |
$58.74 |
$59.11 |
1.12M | | 09/28/2023 |
$59.13 |
$59.33 |
$58.45 |
$58.61 |
795.20K | | 09/29/2023 |
$58.86 |
$58.86 |
$57.66 |
$57.77 |
1.43M |
|
|
| Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) is Co.'s initial product approved by the U.S. Food and Drug Administration for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea, for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older and for the treatment of chronic GVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older. | |
|
Incyte (INCY) has the following price history information. Looking back at INCY historical stock prices for the last five trading days, on September 25, 2023, INCY opened at $58.05, traded as high as $58.83 and as low as $57.90, and closed at $58.75. Trading volume was a total of 1.90M shares. On September 26, 2023, INCY opened at $58.56, traded as high as $59.62 and as low as $58.52, and closed at $59.28. Trading volume was a total of 1.47M shares. On September 27, 2023, INCY opened at $59.46, traded as high as $59.85 and as low as $58.74, and closed at $59.11. Trading volume was a total of 1.12M shares. On September 28, 2023, INCY opened at $59.13, traded as high as $59.33 and as low as $58.45, and closed at $58.61. Trading volume was a total of 795.20K shares. On September 29, 2023, INCY opened at $58.86, traded as high as $58.86 and as low as $57.66, and closed at $57.77. Trading volume was a total of 1.43M shares.
INCY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Incyte shares, starting with a $10,000 purchase of INCY, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/02/2013 |
|
| End date: |
09/29/2023 |
|
| Start price/share: |
$40.38 |
|
| End price/share: |
$57.77 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
43.07% |
|
| Average Annual Total Return: |
3.65% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$14,310.36 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 09/25/2023 | $58.75 | | 09/26/2023 | $59.28 | | 09/27/2023 | $59.11 | | 09/28/2023 | $58.61 | | 09/29/2023 | $57.77 |
|
|
Free INCY Email Alerts:
